21 dage efter den anden injektion havde 84% af de personer, der havde fået vaccinen, antistofniveauer, som beskyttede dem mod H5N1.
At 21 days after the second injection, 84% of the people receiving the vaccine had levels of antibodies that would protect them against H5N1.